PA
Perceptive Advisors Portfolio holdings
AUM
$3.46B
1-Year Est. Return
112.42%
1 Year Est. Return
+112.42%
AUM
$3.46B
AUM Growth
+$796M
(+30%)
Holding
103
Top Buys
| 1 | +$70.8M | |
| 2 | +$65.4M | |
| 3 | +$61.1M | |
| 4 |
Merus
MRUS
|
+$60.7M |
| 5 |
Penumbra
PEN
|
+$47.6M |
Top Sells
| 1 | +$532M | |
| 2 | +$36.1M | |
| 3 | +$32.8M | |
| 4 |
BBNX
Beta Bionics
BBNX
|
+$26.1M |
| 5 |
Evolus
EOLS
|
+$22.8M |
Sector Composition
| 1 | Healthcare | 99.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rhythm Pharmaceuticals
RYTM
$6.98B
| $288M | 8.33% |
2,438,969
+20,670
|
|
||
2
Ascendis Pharma
ASND
$12.3B
| $216M | 6.25% |
1,088,501
+124,615
|
|
||
3
Arcellx
ACLX
$4.22B
| $203M | 5.85% |
2,468,353
-9,647
|
|
||
4
Celcuity
CELC
$4.63B
| $146M | 4.22% |
2,956,319
+1,323,111
|
|
||
5
Nuvalent
NUVL
$8.3B
| $135M | 3.9% |
1,562,336
+187,156
|
|
||
|
6
Merus
MRUS
$7.29B
| $127M | 3.68% |
1,353,093
+644,917
|
|
||
7
Amylyx Pharmaceuticals
AMLX
$1.56B
| $122M | 3.51% |
8,952,365
+1,050,000
|
|
||
8
Roivant Sciences
ROIV
$14.4B
| $111M | 3.22% |
7,368,461
+4,036,996
|
|
||
9
MeiraGTx Holdings
MGTX
$654M
| $104M | 3% |
12,626,103
|
|
||
10
Insmed
INSM
$44.1B
| $101M | 2.92% |
702,130
+51,878
|
|
||
11
Travere Therapeutics
TVTX
$3.12B
| $90.7M | 2.62% |
3,794,615
+2,960,363
|
|
||
12
Artivion
AORT
$2.15B
| $85.5M | 2.47% |
2,020,000
-773,703
|
|
||
13
Praxis Precision Medicines
PRAX
$4.66B
| $82.9M | 2.39% |
1,564,554
+811,633
|
|
||
14
Immatics
IMTX
$1.26B
| $79.9M | 2.31% |
9,383,456
|
|
||
|
CNTA
15
Centessa Pharmaceuticals
CNTA
$4.3B
| $75.2M | 2.17% |
3,100,902
+1,953,967
|
|
||
16
Solid Biosciences
SLDB
$404M
| $73M | 2.11% |
11,833,539
-73,107
|
|
||
17
Protagonist Therapeutics
PTGX
$5.38B
| $68.4M | 1.98% |
1,030,134
-44,314
|
|
||
18
Neurocrine Biosciences
NBIX
$15.2B
| $63.2M | 1.82% |
450,050
+195,000
|
|
||
19
Edgewise Therapeutics
EWTX
$2.47B
| $61.6M | 1.78% |
3,795,894
-844,055
|
|
||
|
VRNA
20
DELISTED
Verona Pharma
VRNA
| $55.9M | 1.61% |
524,088
-4,983,503
|
|
||
|
21
Penumbra
PEN
$11.2B
| $55.9M | 1.61% |
220,547
+187,750
|
|
||
22
Akero Therapeutics
AKRO
$4.5B
| $53.9M | 1.56% |
1,135,766
+219,879
|
|
||
23
Apogee Therapeutics
APGE
$5.09B
| $53.7M | 1.55% |
1,351,989
+169,841
|
|
||
|
OMDA
24
Omada Health Inc
OMDA
$934M
| $53M | 1.53% |
2,396,330
-30,000
|
|
||
25
Amicus Therapeutics
FOLD
$3.02B
| $50.2M | 1.45% |
6,370,851
-1,041,979
|
|